Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Tobrazin Plus - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Tobrazin Plus

Approved

STANDARD

Tobrazin Plus

Scott-Edil Pharmacia Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 7451e6ee439b5e8b
Company: Scott-Edil Pharmacia Ltd.
Type: Standard

Approval Details

Approval Id: 7451e6ee439b5e8b
Drug Approval Philippines Name: Tobrazin Plus
Product Name: Tobrazin Plus
Registration Number: DRP-15855
Brand Name: Tobrazin Plus
Generic Name: Tobramycin (as sulfate) + Dexamethasone sodium phosphate
Dosage Form: Ophthalmic Solution (Drops)
Dosage Strength: 3 mg/1 mg (0.3% / 0.1%) per mL
Manufacturer: Scott-Edil Pharmacia Ltd.
Importer: Greencore Pharma Inc.
Distributor: Greencore Pharma Inc.
Issuance Date: 25 September 2024
Expiry Date: 25 September 2029
Pharmacologic Category: Antibacterial/Corticosteroid
Classification: Prescription (Rx) Drug

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

7451e6ee439b5e8b

Type

Standard

Back to Philippines FDA Approvals